Zelosdx, Inc. received a $255,763 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041). The grant funding supports research titled "Phagocytic Cells in Peripheral Blood as a Novel Diagnostic Tool for Brain Health" from August 1, 2021 through July 31, 2022. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This particular award appears aimed at furthering the development of a non-invasive diagnostic tool using peripheral blood to assess brain health conditions, with the goal of advancing innovative biomedical engineering solutions.
Generated 1/7/24, 3:25 AM